Abraham Abuchowski

Founder at Prolong Pharmaceuticals LLC

Abraham Abuchowski

Abraham Abuchowski

Founder at Prolong Pharmaceuticals LLC

Biography

Abraham Abuchowski founded Biotechnology Council of New Jersey, Inc. and Prolong Pharmaceuticals LLC. Dr. Abuchowski is Chief Executive & Science Officer at Prolong Pharmaceuticals LLC. In his past career he occupied the position of Chairman & Chief Executive Officer of Enzon Pharmaceuticals, Inc. and Chairman of Biotechnology Council of New Jersey, Inc. He received a doctorate and an undergraduate degree from Rutgers State University of New Jersey.

Overview
Career Highlights

Enzon Pharmaceuticals Inc.
Prolong Pharmaceuticals LLC
Biotechnology Council of New Jersey, Inc.

RelSci Relationships

113

Number of Boards

2

Number of Awards

1
Relationships
View Relationship Details
RelSci Relationships are individuals Abraham Abuchowski likely has professional access to. A relationship does not necessarily indicate a personal connection.
Glenn Kazo

President at Prolong Pharmaceuticals LLC

Relationship likelihood: Strong

Doug VanBruggen

Controller at Prolong Pharmaceuticals LLC

Relationship likelihood: Strong

Zachary C. Berk

Co-Founder at KBL Healthcare Management, Inc.

Relationship likelihood: Strong

Lihsyng Stanford Lee

Former Development Director at Prolong Pharmaceuticals LLC

Relationship likelihood: Strong

Elijah W. Berk

Executive Vice President at KBL Acquisition Corp. IV

Relationship likelihood: Strong

Arthur Higgins

President & Chief Executive Officer at Assertio Therapeutics, Inc.

Relationship likelihood: Strong

Ronald Jubin

Vice President, R&D at Prolong Pharmaceuticals LLC

Relationship likelihood: Strong

Marlene R. Krauss

Chief Executive Officer, Principal Financial & Accounting Officer & Director at KBL Merger Corp. IV

Relationship likelihood: Strong

Donald Lee Drakeman

Venture Partner at Advent Life Sciences LLP

Relationship likelihood: Strong

Richard Prince

Vice President-Quality at Prolong Pharmaceuticals LLC

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
Business Wire
April 17, 2015
BioNJ & NJDLWD Present New Jersey Life Sciences Week, April 20-24: Building the Dynamic Ecosystem of the Life Sciences Industry in New Jersey
PR Newswire
April 14, 2015
Prolong Pharmaceuticals Presents Data on Unique "Un-Sickling" In Vitro Activity Observed in Sickle Cell Investigational Drug SANGUINATE: Anti-inflammatory Activity Also Noted In Drug, Currently In Phase II Trials
PR Newswire
April 8, 2015
Prolong Pharmaceuticals' Flagship Product SANGUINATE(TM) Granted Orphan Drug Designation by the FDA: Novel Product Focused On Treatment of Comorbidities of Sickle Cell Disease
Business Wire
February 5, 2015
BioNJ's Gateway Gala to Salute Patients And the Innovator Companies Inspired by Them
PR Newswire
December 18, 2013
Prolong Pharmaceuticals Adds Industry Veteran Ronald Jubin To Executive Management Team
Trending People
Gretchen Whitmer
Washington turned into fortress ahead of Biden's swearing-in; Troops lock down U... - The Straits Times (Singapore)
Barack Obama
Bestsellers - The Straits Times (Singapore)
Angela Merkel
Germany: Merkel's party elects pragmatic Laschet as leader - St. Paul Pioneer Press (Minnesota)
Boris Johnson
Brexit: How travel to the EU has changed - The Independent UK
Kamala D. Harris
INAUGURATION EXPLAINER: Biden's event will be very different - The Canadian Press
Trending People
Gretchen Whitmer
Washington turned into fortress ahead of Biden's swearing-in; Troops lock down U... - The Straits Times (Singapore)
Barack Obama
Bestsellers - The Straits Times (Singapore)
Angela Merkel
Germany: Merkel's party elects pragmatic Laschet as leader - St. Paul Pioneer Press (Minnesota)
Boris Johnson
Brexit: How travel to the EU has changed - The Independent UK
Kamala D. Harris
INAUGURATION EXPLAINER: Biden's event will be very different - The Canadian Press
Paths to Abraham Abuchowski
Potential Connections via
Relationship Science
You
Abraham Abuchowski
Founder at Prolong Pharmaceuticals LLC
Education
Ph.D, Biochemistry
Rutgers University

Rutgers, The State University of New Jersey, is a leading national research university and the state’s preeminent, comprehensive public institution of higher education. Rutgers is dedicated to teaching that meets the highest standards of excellence; to conducting research that breaks new ground; and to providing services, solutions, and clinical care that help individuals and the local, national, and global communities where they live. Founded in 1766, Rutgers teaches across the full educational spectrum: preschool to precollege; undergraduate to graduate; postdoctoral fellowships to residencies; and continuing education for professional and personal advancement.

Career History
Founder
2002 - Current
Prolong Pharmaceuticals LLC

Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ.

Founder
1994 - Prior
Biotechnology Council of New Jersey, Inc.

Chairman & Chief Executive Officer
1981 - 1994
Enzon Pharmaceuticals Inc.

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.

Boards & Committees
Chairman & Chief Executive Officer
1981 - 1994
Enzon Pharmaceuticals Inc.

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.

Chairman, Board of Trustees
1994 - Prior
Biotechnology Council of New Jersey, Inc.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100 - $249
2011
New Jersey Symphony Orchestra

The New Jersey Symphony Orchestra (NJSO) is an American symphony orchestra based in the state of New Jersey. The NJSO is the state orchestra of New Jersey, performing concert series in six venues across the state, and is the resident orchestra of the New Jersey Performing Arts Center (NJPAC) in Newark, New Jersey.

$100 - $249
2010
New Jersey Symphony Orchestra

The New Jersey Symphony Orchestra (NJSO) is an American symphony orchestra based in the state of New Jersey. The NJSO is the state orchestra of New Jersey, performing concert series in six venues across the state, and is the resident orchestra of the New Jersey Performing Arts Center (NJPAC) in Newark, New Jersey.

$2,500 +
2006
Aopa Air Safety Foundation, Inc.

Political Donations
$250
2012
Joseph M. Kyrillos

Senior Managing Director at Newmark & Company Real Estate, Inc.

$150
2009
Steven M. Lonegan

Director of Monetary Policy at American Principles Project

$300
2009
CLUB FOR GROWTH ACTION

Investments
Details Hidden
Prolong Pharmaceuticals LLC

Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ.

Awards & Honors
2002
Rutgers Hall of Distinguished Alumni
Other Affiliations

Abraham Abuchowski is affiliated with Prolong Pharmaceuticals LLC, Biotechnology Council of New Jersey, Inc., Enzon Pharmaceuticals Inc., Enzon Pharmaceuticals Inc., Biotechnology Council of New Jersey, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Abraham Abuchowski. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Abraham Abuchowski's profile does not indicate a business or promotional relationship of any kind between RelSci and Abraham Abuchowski.